Do analysts prefer BTCY or INBS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts recommend BTCY or NVNO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Which has stronger earnings and valuation, BTCY or SONX?

Biotricity has higher earnings, but lower revenue than Sonendo. Biotricity is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biotricity $12.06M 0.14 -$14.09M -$0.14 N/A Sonendo $44.40M 0.14 -$60.92M -$71.12 N/A

Is BTCY or SONX more profitable?

Biotricity has a net margin of -80.42% compared to Sonendo's net margin of -92.74%. Biotricity's return on equity of 0.00% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets Biotricity -80.42% N/A -188.47% Sonendo -92.74% -184.01% -68.60%

Do analysts recommend BTCY or AMIX?

Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 897.62%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Biotricity. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend ZYXI or BTCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, ZYXI or BTCY?

Zynex has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A Biotricity $12.06M 0.14 -$14.09M -$0.14 N/A

Is ZYXI or BTCY more profitable?

Zynex has a net margin of -68.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Biotricity -80.42% N/A -188.47%

Biotricity (BTCY) Competitors

$0.08 0.00 (-2.31%)

As of 09/18/2026 03:49 PM Eastern

Compare

BTCY vs. INBS, NVNO, SONX, AMIX, and ZYXI

Should you buy Biotricity stock or one of its competitors? Biotricity's main competitors and comparable companies include Intelligent Bio Solutions (INBS), enVVeno Medical (NVNO), Sonendo (SONX), Autonomix Medical (AMIX), and Zynex (ZYXI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Biotricity compare to Intelligent Bio Solutions?

Biotricity (NASDAQ:BTCY) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Biotricity has a net margin of -80.42% compared to Intelligent Bio Solutions' net margin of -294.88%. Biotricity's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%

Intelligent Bio Solutions has lower revenue, but higher earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.14	-$14.09M	-$0.14	N/A
Intelligent Bio Solutions	$4.22M	1.52	-$12.43M	-$9.02	N/A

In the previous week, Biotricity's average media sentiment score of 0.00 equaled Intelligent Bio Solutions'average media sentiment score.

Company	Overall Sentiment
Biotricity	Neutral
Intelligent Bio Solutions	Neutral

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 1.6% of Biotricity shares are owned by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Biotricity has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.25, indicating that its share price is 325% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Biotricity and Intelligent Bio Solutions tied by winning 6 of the 12 factors compared between the two stocks.

How does Biotricity compare to enVVeno Medical?

Biotricity (NASDAQ:BTCY) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

Biotricity has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Biotricity has higher revenue and earnings than enVVeno Medical. Biotricity is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.14	-$14.09M	-$0.14	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

3.9% of Biotricity shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 1.6% of Biotricity shares are held by insiders. Comparatively, 15.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

enVVeno Medical has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat enVVeno Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
enVVeno Medical	N/A	-62.28%	-56.83%

In the previous week, enVVeno Medical had 4 more articles in the media than Biotricity. MarketBeat recorded 4 mentions for enVVeno Medical and 0 mentions for Biotricity. Biotricity's average media sentiment score of 0.00 beat enVVeno Medical's score of -0.81 indicating that Biotricity is being referred to more favorably in the media.

Company	Overall Sentiment
Biotricity	Neutral
enVVeno Medical	Negative

Summary

Biotricity and enVVeno Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Biotricity compare to Sonendo?

Biotricity (NASDAQ:BTCY) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

Biotricity has higher earnings, but lower revenue than Sonendo. Biotricity is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.14	-$14.09M	-$0.14	N/A
Sonendo	$44.40M	0.14	-$60.92M	-$71.12	N/A

Biotricity has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market. Comparatively, Sonendo has a beta of 1.81, indicating that its stock price is 81% more volatile than the broader market.

3.9% of Biotricity shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 1.6% of Biotricity shares are held by insiders. Comparatively, 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Biotricity's average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score.

Company	Overall Sentiment
Biotricity	Neutral
Sonendo	Neutral

Biotricity has a net margin of -80.42% compared to Sonendo's net margin of -92.74%. Biotricity's return on equity of 0.00% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Sonendo	-92.74%	-184.01%	-68.60%

Summary

Sonendo beats Biotricity on 6 of the 11 factors compared between the two stocks.

How does Biotricity compare to Autonomix Medical?

Biotricity (NASDAQ:BTCY) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Biotricity has higher revenue and earnings than Autonomix Medical. Biotricity is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.14	-$14.09M	-$0.14	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

3.9% of Biotricity shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 1.6% of Biotricity shares are held by insiders. Comparatively, 6.2% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 897.62%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Biotricity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Autonomix Medical had 2 more articles in the media than Biotricity. MarketBeat recorded 2 mentions for Autonomix Medical and 0 mentions for Biotricity. Biotricity's average media sentiment score of 0.00 beat Autonomix Medical's score of -0.12 indicating that Biotricity is being referred to more favorably in the media.

Company	Overall Sentiment
Biotricity	Neutral
Autonomix Medical	Neutral

Autonomix Medical has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Autonomix Medical	N/A	-267.73%	-216.75%

Biotricity has a beta of 1.16, meaning that its share price is 16% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1, meaning that its share price is 200% less volatile than the broader market.

Summary

Biotricity beats Autonomix Medical on 8 of the 15 factors compared between the two stocks.

How does Biotricity compare to Zynex?

Zynex (NASDAQ:ZYXI) and Biotricity (NASDAQ:BTCY) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Zynex has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Biotricity	$12.06M	0.14	-$14.09M	-$0.14	N/A

29.7% of Zynex shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 49.3% of Zynex shares are held by company insiders. Comparatively, 1.6% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Zynex has a net margin of -68.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Biotricity	-80.42%	N/A	-188.47%

Zynex has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, Biotricity has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Zynex's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.

Company	Overall Sentiment
Zynex	Neutral
Biotricity	Neutral

Summary

Zynex beats Biotricity on 8 of the 12 factors compared between the two stocks.

Get Biotricity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BTCY vs. The Competition

Export

Metric	Biotricity	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.70M	$5.57B	$7.24B	$13.21B
Dividend Yield	N/A	1.80%	2.57%	12.80%
P/E Ratio	-0.08	25.34	275.49	25.40
Price / Sales	0.14	43.73	639.55	86.82
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	-0.07	5.69	10.46	6.33
Net Income	-$14.09M	$151.55M	$3.49B	$358.33M
7 Day Performance	N/A	0.66%	0.59%	1.12%
1 Month Performance	N/A	-3.33%	-1.74%	-2.39%
1 Year Performance	N/A	6.79%	18.13%	5.35%

Biotricity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BTCY Biotricity	N/A	$0.08 -2.3%	N/A	-86.6%	$1.70M	$12.06M	N/A	46	Gap Up
INBS Intelligent Bio Solutions	1.2717 of 5 stars	$2.00 +1.5%	N/A	-85.4%	$6.53M	$4.22M	N/A	10
NVNO enVVeno Medical	1.8078 of 5 stars	$8.85 -2.3%	N/A	-72.5%	$6.29M	N/A	N/A	30
SONX Sonendo	N/A	$1.30 flat	N/A	N/A	$6.21M	$44.40M	N/A	250
AMIX Autonomix Medical	2.4751 of 5 stars	$4.28 +3.9%	$42.00 +881.3%	-81.1%	$4.00M	N/A	N/A	1	Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BTCY) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biotricity (BTCY) Competitors

BTCY vs. INBS, NVNO, SONX, AMIX, and ZYXI

How does Biotricity compare to Intelligent Bio Solutions?

Summary

How does Biotricity compare to enVVeno Medical?

Summary

How does Biotricity compare to Sonendo?

Summary

How does Biotricity compare to Autonomix Medical?

Summary

How does Biotricity compare to Zynex?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY vs. The Competition

Biotricity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biotricity (BTCY) Competitors

BTCY vs. INBS, NVNO, SONX, AMIX, and ZYXI

How does Biotricity compare to Intelligent Bio Solutions?

Is BTCY or INBS more profitable?

Which has preferable valuation & earnings, BTCY or INBS?

Does the media prefer BTCY or INBS?

Do insiders & institutionals hold more shares of BTCY or INBS?

Which has more risk & volatility, BTCY or INBS?

Do analysts prefer BTCY or INBS?

Summary

How does Biotricity compare to enVVeno Medical?

Which has more risk and volatility, BTCY or NVNO?

Do analysts recommend BTCY or NVNO?

Which has preferable earnings & valuation, BTCY or NVNO?

Do institutionals and insiders have more ownership in BTCY or NVNO?

Is BTCY or NVNO more profitable?

Does the media refer more to BTCY or NVNO?

Summary

How does Biotricity compare to Sonendo?

Which has stronger earnings and valuation, BTCY or SONX?

Which has more volatility and risk, BTCY or SONX?

Do institutionals & insiders believe in BTCY or SONX?

Does the media refer more to BTCY or SONX?

Is BTCY or SONX more profitable?

Summary

How does Biotricity compare to Autonomix Medical?

Which has preferable earnings and valuation, BTCY or AMIX?

Do insiders and institutionals have more ownership in BTCY or AMIX?

Do analysts recommend BTCY or AMIX?

Does the media favor BTCY or AMIX?

Is BTCY or AMIX more profitable?

Which has more risk & volatility, BTCY or AMIX?

Summary

How does Biotricity compare to Zynex?

Which has stronger earnings and valuation, ZYXI or BTCY?

Do insiders & institutionals have more ownership in ZYXI or BTCY?

Is ZYXI or BTCY more profitable?

Which has more volatility and risk, ZYXI or BTCY?

Do analysts recommend ZYXI or BTCY?

Does the media refer more to ZYXI or BTCY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY vs. The Competition

Biotricity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools